123 related articles for article (PubMed ID: 7440976)
1. Stability of DNA/ANTI-DNA complexes. IV. Complement fixation.
Pedersen SE; Taylor RP; Morley KW; Wright EL
J Immunol Methods; 1980; 38(3-4):269-80. PubMed ID: 7440976
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of anti-dsDNA antibodies and antibody/dsDNA stoichiometries in prepared, soluble complement-fixing antibody/dsDNA immune complexes.
Taylor RP; Horgan C
Mol Immunol; 1984 Oct; 21(10):853-62. PubMed ID: 6334233
[TBL] [Abstract][Full Text] [Related]
3. Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.
Horgan C; Taylor RP
Arthritis Rheum; 1984 Mar; 27(3):320-9. PubMed ID: 6546694
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
Taylor RP; Horgan C; Hooper M; Burge J
J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
[TBL] [Abstract][Full Text] [Related]
5. DNA/anti-DNA complexes: correlation of size and complement fixation.
Waller SJ; Taylor RP; Wright EL; Morley KW; Johns M
Arthritis Rheum; 1981 May; 24(5):651-7. PubMed ID: 7236322
[TBL] [Abstract][Full Text] [Related]
6. The interaction of antibody/DNA immune complexes with complement. Influence of antibody class and DNA conformation.
Taylor RP; Edberg JC; Kujala GA; Sloman AJ; Wilson CC; Cronin ME
Arthritis Rheum; 1987 Feb; 30(2):176-85. PubMed ID: 3493781
[TBL] [Abstract][Full Text] [Related]
7. Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays.
Taylor RP; Andrews BS; Morley KW; Conlon T
Rheumatol Int; 1981; 1(1):29-34. PubMed ID: 6981180
[TBL] [Abstract][Full Text] [Related]
8. Complement-fixing anti--double-stranded DNA with the Crithidia method: a better indicator of active SLE than anti-DNA with the Farr method.
Huber O; Greenberg ML; Huber J
J Lab Clin Med; 1979 Jan; 93(1):32-9. PubMed ID: 366049
[TBL] [Abstract][Full Text] [Related]
9. Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal.
Esparza RH; Swaak T; Aarden L; Smeenk R
J Rheumatol; 1985 Dec; 12(6):1109-17. PubMed ID: 3912506
[TBL] [Abstract][Full Text] [Related]
10. Stability of DNA/anti-DNA complexes. II. Salt lability and avidity.
Riley RL; Addis DJ; Taylor RP
J Immunol; 1980 Jan; 124(1):1-7. PubMed ID: 6985634
[TBL] [Abstract][Full Text] [Related]
11. Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity.
Smeenk RJ; Van Rooijen A; Swaak TJ
J Immunol Methods; 1988 Apr; 109(1):27-35. PubMed ID: 3282012
[TBL] [Abstract][Full Text] [Related]
12. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
13. Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity.
Mackworth-Young CG; Chan JK; Bunn CC; Hughes GR; Gharavi AE
Ann Rheum Dis; 1986 Apr; 45(4):314-8. PubMed ID: 3486639
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
Horgan C; Burge J; Crawford L; Taylor RP
J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
[TBL] [Abstract][Full Text] [Related]
15. Interaction between rheumatoid factor and antibody/DNA complexes: enhancement of complement fixation.
Birchmore DA; Taylor RP; Waller SJ; Davis JS; Morley KW
Arthritis Rheum; 1981 Mar; 24(3):527-33. PubMed ID: 7213431
[TBL] [Abstract][Full Text] [Related]
16. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
[TBL] [Abstract][Full Text] [Related]
17. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
Williams DG; Adu D
Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
[TBL] [Abstract][Full Text] [Related]
18. A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus.
Lindorfer MA; Schuman TA; Craig ML; Martin EN; Taylor RP
J Immunol Methods; 2001 Feb; 248(1-2):125-38. PubMed ID: 11223074
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
Edberg JC; Wright E; Taylor RP
J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
[TBL] [Abstract][Full Text] [Related]
20. Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients.
Hashimoto H; Tsuda H; Takasaki Y; Fujimaki N; Suzuki M; Shiokawa Y
J Rheumatol; 1983 Oct; 10(5):727-32. PubMed ID: 6606040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
